The market value of the Gonggong Financial and Economic Bureau has shrunk by more than 8% in the two years since its listing, and it is difficult for Eagle Eye Technology to break through the "profit" barrier
Two years ago, on November 5, Eagle Eye Technology landed on the Hong Kong Stock Exchange with the halo of "the first share of medical AI", although it broke on the first day of listing, but the market value of up to 7 billion Hong Kong dollars still made it unparalleled for a while. However, no one expected that the listing of Eagle Eye Technology was the peak, and as of December 4, 2023, Eagle Eye Technology closed at 11HK$62 shares, the latest market capitalization is only HK$1.2 billion, a decrease of more than 80% compared with the all-time high.
Obviously based on cutting-edge technology - AI medical care, why is the market performance of Eagle Eye Technology **double heaven??
From 2019 to 2022, Eagle Eye Technology's revenue was 3041500,000 yuan, 4767200,000 yuan, 11.5 billion yuan and 113.7 billion, the annual losses were 87.14 million, 80.06 million, and 142.6 billion, 180 billion. For the retreat in 2022, Eagle Eye blamed the epidemic, saying that due to the restrictions on on-site activities applied to the company's products in relevant business scenarios during the reporting period, business operations were adversely affected. However, as time came to the first half of this year, Eagle Eye Technology's revenue increased by 120 despite a low base6%, but the loss continued, and the net loss attributable to the parent during the period reached 36.97 million yuan.
Judging from the financial report, the main reason for the loss of Eagle Pupil is that the salary for employees is too high. Taking the first half of this year as an example, as of June 30, 2023, Eagle Eye had 369 full-time employees, and the total compensation cost (including share-based payments) incurred was RMB98.1 million. In other words, the cost of employee compensation is nearly 100 million, and the total revenue of Eagle Pupil in the first half of the year is only 82.5 million, and the money received is not enough to pay employees' salaries.
It is worth noting that Eagle Pupil's "generosity" to employees is not recent. As of December 31, 2022, Eagle Eye Technology's total compensation costs (including share-based payments) were RMB21.6 billion yuan, while this figure was 13 billion yuan, which is much higher than the operating income of Eagle Pupil in the same period, so it is no wonder that it will lose money if it cannot make ends meet.
Not only that, since the beginning of this year, the management of Eagle Eye Technology has encountered great turmoil. In January this year, Gao Fei, co-founder of Eagle Eye Technology, resigned as executive director and ceased to be a member of the company's remuneration and appraisal committee, citing the need to devote more time to his family and other work arrangements. In July this year, Zhu Zhouyao, a non-executive director of Eagle Eye Technology, resigned as a director due to other work arrangements. Recently, the results of the general election of the second board of directors and the board of supervisors disclosed by Eagle Eye Technology show that Dr. Chen Yuzhong and Mr. Chen Hailong will retire as executive directors in rotation, and Mr. Chen Xin will retire as non-executive directors in rotation. Dr. Chen Yuzhong and Mr. Chen Hailong will continue to serve in the Group and shift their focus to the day-to-day operation management and business development of the Group. In place of Chen Yuzhong and Chen Hailong's executive directors, Dr. He Chao and Mr. Qin Yong. According to the announcement, Hechao joined Eagle Eye Technology as the chief technology officer on October 23, 2018. Mr. Qin Yong joined Eagle Eye in September 2017 as Product Operations Manager.
In addition to the lack of control in human resources, in terms of products, Eagle Eye Technology's large single fundus camera also suffered a recall in October this year, due to the problem of incorrect version of the product manual, Shanghai Eagle Eye Medical Technology *** voluntarily recalled the fundus camera (registration certificate number: Shanghai Machinery Note 20222160205) produced by it. The recall level is **. Although only the recall instructions and not the products are recalled, it still puts a question mark on the company's product strength.
url: *in: Business Huaguan.
Statement from the Social Finance Bureau: This article is for the purpose of conveying more information. If there is a ** marking error or infringement of your legitimate rights and interests, please contact this website with the author's ownership certificate, and we will correct and delete it in time, thank you. E-mail address: [email protected]